Celebrating the Women Researchers Driving Progress in Follicular Lymphoma Research
This International Women’s Day the FLF and our global community are proud to celebrate and highlight the exceptional women whose scientific insight, dedication and innovation are driving progress in follicular lymphoma research.
Webinar: Your Health Data: How it Powers Research
Could your health data help improve care for people living with follicular lymphoma?
Watch our free webinar with lymphoma expert Dr Peter Martin, patient advocate Chris Carrigan, and FLF’s Chief Medical Officer Dr Mitchell Smith to learn how health data is helping shape the future of FL research and what it means for you.
Science simplified- Who needs treatment and when?
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Claire’s Story
Being a doctor and an oncology patient at the same time was a really strange experience. I was in disbelief for a long time. I just could not believe that these things that I had learnt about and read about for years were now happening to me. I had always felt so strong, invincible almost. It makes you realise how vulnerable we all really are.
Science simplified- how to make sense of research
In our upcoming “Science Simplified” series, we’ll be sharing insights from the latest research presented to us at the American Society of Hematology(ASH) conference . But before we explore that in detail, it is important to explain how we, and you, can read research critically.
Latest Research Breakthroughs at ASH 2025: How We’re Accelerating the Search for a Cure
Every December, over 30,000 haematology experts from around the world gather for the American Society of Haematology (ASH) conference, where groundbreaking research is shared and the future of lymphoma treatment takes shape. In December 2025, the FLF team was at ASH in Orlando, USA on a clear mission: to find out the latest breakthroughs, represent you and drive progress toward a cure for follicular lymphoma.